Top Tweets for #Syena
Sound on 🔊
The engine of SY Ena — built in 1900, still stealing the show.
Mechanical ASMR at its finest. ⚙️
#SteamEngine #SteamYacht #SeaMuseum #SYEna
Happy to report that @replaybio & @MDAndersonNews received @US_FDA clearance for the IND application of our first-in-class PRAME TCR-NK cell therapy PRAME TCR/IL-15 NK platform for #AML #MDS and #MultipleMyeloma, developed by our product company, #Syena.
https://t.co/gQJRNLGcct
With @MDAndersonNews, we announce @US_FDA clearance for the IND application of our PRAME TCR/IL-15 NK #cellTherapy in #AML, #MDS and #multipleMyeloma developed by our #oncology product company #Syena. The phase 1/2 study is expected to commence in Q3 2024.https://t.co/Zb9qejrMOc
I thoroughly enjoyed speaking with @PrecMedOnline, on how #Syena, our oncology-focused product company developing TCR-NK #celltherapies, is pioneering immunotherapy research in the treatment of solid tumors and blood cancer.
https://t.co/VWyeYyAFnZ
Today, @Replay announced that the first patient has been dosed in the Ph 1/2 study of NY-ESO-1/IL-15 NK, #Syena’s engineered TCR-NK cell therapy for relapsed/refractory multiple myeloma.
https://t.co/itpIXkcwIt
#genomicMedicine #genomeWriting #Oncology #Syena
We are pleased to announce that the first patient has been dosed in the Ph 1/2 study of NY-ESO-1/IL-15 NK, #Syena’s engineered TCR-NK cell therapy for relapsed/refractory multiple myeloma.
https://t.co/4vkvD0t9W1
#genomicMedicine #genomeWriting #Oncology #Syena
Wrapping up a wonderful year at @Replay by kicking off our #ReplayRewind series, recognizing the remarkable achievements of our team #Replay #Syena #Telaria #Eudora #Kaleibe #GenomicMedicine
Replay’s #Syena signs two exclusive licensing & manufacturing agreements with, @miltenyibiotec (to support the development of a GMP-compliant PRAME TCR-NK cell therapy), and @NIH (to develop TCRs directed against multiple cancer neoantigens) https://t.co/OqGNqyekLH
Replay’s #Syena, signs two exclusive licensing & manufacturing agreements - with @miltenyibiotec to support the development of a GMP-compliant TCR-NK #celltherapy and with @NIH to develop a library of #TCR’s directed against multiple cancer neoantigens https://t.co/PXXKknXyto
Congratulations to Katy Rezvani @lab_rezvani from @MDAndersonNews and scientific cofounder of @replaybio engineered #cordblood #NK #TCR #CellTherapy product company #Syena on being awarded the E Donnall Thompson Prize by #ASH2023 #ASHNewsDaily. A huge and well-deserved honor!
Interesting piece on Katy Rezvani @lab_rezvani from @MDAndersonNews and scientific founder of @replaybio engineered #Oncology #cordblood #TCR #NK #CellTherapy product company #Syena detailing her experiences of being a former refugee from Iran.
https://t.co/i8fI4q0ufQ
I’m thrilled to share more news today from @replaybio & @MDAndersonNews. We have received our second @US_FDA clearance for the IND application of our first-in-class TCR-NK #celltherapy for #MultipleMyeloma, being developed in our product company, #Syena https://t.co/K30RZDlAr6
Today, with @MDAndersonNews, we announce @US_FDA clearance for the IND application of our TCR-NK #celltherapy in #MultipleMyeloma. This is the 2nd IND clearance for NY-ESO TCR/IL-15 NK, being developed in our #oncology product company, #Syena.
More here: https://t.co/wUy21H9c9T
I’m delighted to announce that @replaybio & @MDAndersonNews have received @US_FDA clearance for the IND application of our first-in-class TCR-#NK #celltherapy for #sarcoma, developed within our #oncology product company, #Syena. For more: https://t.co/c1OGZJZINa
Today, together with @MDAndersonNews, we announce @US_FDA clearance for the IND application of our first-in-class TCR-NK #celltherapy for #sarcoma, NY-ESO TCR/IL-15 NK, which is being developed within our #oncology product company, #Syena.
More here: https://t.co/mSuSyJtYnX
Biotech #startup @replaybio is joining forces with The University of Texas @MDAndersonNews to launch #Syena, an oncology company that will develop #Tcell receptor (TCR) natural killer (NK) cell therapies. #celltherapy #partnership #biotech
Read more: https://t.co/yuvU78j79V
.@MDAndersonNews and @replaybio Form #Syena to Develop Novel TCR NK Cell Therapy
Syena will receive licenses to various Replay cell and genome engineering platform technologies. Learn more: https://t.co/Y03dEdGMCZ
.@MDAndersonNews and @replaybio Form #Syena to Develop Novel TCR NK Cell Therapy
Syena will receive licenses to various Replay cell and genome engineering platform technologies. Learn more: https://t.co/Y03dEdHksx
Replay rolls again, creating TCR-NK cell therapy startup with MD Anderson to close in on clinic - More like this https://t.co/Ch0OzV8Nyh | @replaybio @MDAndersonNews #Syena #Oncology #TCR-NK #CellTherapy #Startups #Biotech #Research https://t.co/qR7AQUxwDV
Last Seen Hashtags on Sotwe
minichat
Seen from Turkey
Chastity femboy
Seen from Mexico
minichat filter:videos
Seen from United States
mersingay
Seen from Turkey
diyarbakırtravesti
Seen from Turkey
moaningcewe
Seen from Indonesia
incest()
Seen from Turkey
pepers
Seen from Italy
MGAI
Seen from United States
minichat(((((((***(**)*****))))))) +filter:native_video
Seen from India
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers